Merck reports breakthrough Phase 3 win for sac-TMT in endometrial cancer

Astrazeneca’s Baxfendy wins US approval as first-in-class hypertension drug

Baxfendy works in a fundamentally different way from current therapies

Lupin launches Atharv ability neuro-rehabilitation centre in Delhi

New Delhi facility expands Lupin’s specialized neuro-rehabilitation network after Mumbai and Hyderabad launches

Women’s hospital opens in Delhi with $5 million backing

30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage

Mankind launches ‘Act at 30’ campaign to push early heart health screening

Nationwide preventive health initiative aims to make cardiovascular screening at age 30 a standard healthcare milestone

Africa CDC warns of regional Ebola spread risk as DRC and Uganda confirm outbreaks

Africa CDC activates continental coordination measures; consultations underway on possible Public Health Emergency declaration

Experts calls for urgent preventive action as hypertension cases rise

Union Minister Prataprao Jadhav terms hypertension a “silent killer”; experts push for early screening, lifestyle correction and wellness-focused healthcare

RAG launches lupus patient support group in Ahmedabad

The initiative by Rheumatology Association of Gujarat is aimed at strengthening patient-centric autoimmune care

Kotak Alts invests Rs. 200 million in Cellogen Therapeutics

Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities

Lupin receives USFDA nod for Famotidine injection

Famotidine Injection USP is a generic version of Pepcid injection to be manufactured at its Nagpur facility for the U.S. market